ORGANIC
LETTERS
2006
Vol. 8, No. 24
5593-5596
Lipases in
Organic Solvents
â-Dipeptide Synthesis in
Xiang-Guo Li and Liisa T. Kanerva*
Department of Pharmacology, Drug DeVelopment and Therapeutics/Laboratory of
Synthetic Drug Chemistry and Department of Chemistry, UniVersity of Turku,
Lemminkaisenkatu 5C, FIN- 20520 Turku, Finland
Received September 20, 2006
ABSTRACT
A number of
â
-dipeptides were prepared by two-step lipase-catalyzed reactions where N-acetylated
â
-amino esters were first activated as
2,2,2-trifluoroethyl esters with Candida antarctica lipase B (CAL-B). The activated esters were then used to acylate a
â-amino ester in the
presence of Candida antarctica lipase A (CAL-A) in dry Et2O or i-Pr2O.
Proteases (also called peptidases) are widely used as catalysts
for enzymatic peptide synthesis, although many synthesis
limiting facts (enzymatic hydrolysis of the formed peptide
chain, enzymatic instability under nonaqueous conditions
where hydrolysis could be prevented, and often limited sub-
strate specificity to certain coded amino acids) exist.1 On
the other hand, lipases are relatively stable and show wide
substrate specificity, and although they catalyze peptide bond
formation, they do not possess amidase activity which is
essential for splitting peptide bonds. Thus far, the use of
lipases in peptide synthesis has been limited to PPL (porcine
pancreatic lipase)- and CRL (lipase from Candida rugosa)-
catalyzed reactions of N-protected amino esters as electro-
philes and free amino esters as nucleophiles.2 These lipase-
catalyzed methods are typically based on the use of coded
or noncoded R-amino acids. In the case of PPL, some doubts
have been expressed due to possible contamination by
proteases.2b
pects.3 Contrary to R-peptides, in vivo tests with proteolytic
enzymes have shown â-peptides to be completely stable
toward proteolysis owing to very high metabolic stability.3a
Peptidomimetic activities of some â-peptides are well
recognized. A â-tetrapeptide (N-Ac-â3hThr-â2hLys-â3hTrp-
â3hPhe-NH2) is an example.3b It forms a â-turn similar to
that in a peptide hormone somatostatin where R-L-Trp and
R-L-Lys residues situate in the turn. Accordingly, the above-
mentioned â-tetrapeptide nicely imitates the R-peptidic
ligand, acting as a potent agonist at the human somatostatin
hsst4 receptor.
Research interest in our laboratory has focused on using
lipases as chiral catalysts in the enantioselective N-acylation
(2) (a) Margolin, A. L.; Klibanov, A. M. J. Am. Chem. Soc. 1987, 109,
3802. (b) West, J. B.; Wong, C.-H. Tetrahedron Lett. 1987, 28, 1629. (c)
Kawashiro, K.; Kaiso, K.; Minato, D.; Sugiyama, S.; Hayashi, H.
Tetrahedron 1993, 49, 4541. (d) So, J.-E.; Kang, S.-H.; Kim, B.-G. Enzyme
Microb. Technol. 1998, 23, 211. (e) Zhang, L.-Q.; Zhang, Y.-D.; Xu, L.;
Li, X.-L.; Yang, X.-C.; Xu, G.-L.; Wu, X.-X.; Gao, H.-Y.; Du, W.-B.;
Zhang, X.-T.; Zhang, X.-Z. Enzyme Microb. Technol. 2001, 29, 129. (f)
Maruyama, T.; Nakajima, M.; Kondo, H.; Kawasaki, K.; Seki, M.; Goto,
M. Enzyme Microb. Technol. 2003, 32, 655.
(3) (a) Seebach, D.; Beck, A. K.; Bierbaum, D. J. Chem. BiodiVers. 2004,
1, 1111. (b) Gademann, K.; Kimmerlin, T.; Hoyer, D.; Seebach, D. J. Med.
Chem. 2001, 44, 2460. (c) Fu¨lo¨p, F.; Martinek, T. A.; To´th, G. K. Chem.
Soc. ReV. 2006, 36, 323.
During the past few years, interest in the enantiomers of
â-amino acids and further in â-peptides has increased
tremendously from both pharmaceutical and chemical as-
(1) Bordusa, F. Chem. ReV. 2002, 102, 4817.
10.1021/ol0623163 CCC: $33.50
© 2006 American Chemical Society
Published on Web 10/26/2006